US EPA

1050992 

Journal Article 

Organic solvents vapor pressure and relative humidity effects on the phase transition rate of α and β forms of tegafur 

Petkune, S; Bobrovs, R; Actiņš, A 

2012 

1 

Pharm Dev Technol
ISSN: 1083-7450 

17 

5 

625-631 

English 

21639726 

10.3109/10837450.2011.565346 

WOS:000307998100010 

The objective of this work was to investigate the relative humidity (RH) and solvent vapor pressure effects on the phase transition dynamics between tegafur polymorphic forms that do not form hydrates and solvates. The commercially available α and β modifications of 5-fluoro-1-(tetrahydro-2-furyl)-uracil, known as the antitumor agent tegafur, were used as model materials for this study. While investigating the phase transitions of α and β tegafur under various partial pressures of methanol, n-propanol, n-butanol, and water vapor, it was determined that the phase transition rate increased in the presence of solvent vapors, even though no solvates were formed. By increasing the relative air humidity from 20% to 80%, the phase transition rate constant of α and β tegafur was increased about 60 times. After increasing the partial pressure of methanol, n-propanol, or n-butanol vapor, the phase transition rate constant did not change, but the extent of phase transformation was increased. In the homologous row of n-alcohols, the phase transition rate constant decreased with increasing carbon chain length. The dependence of phase transformation extent versus the RH corresponded to the polymolecular adsorption isotherm with a possible capillary condensation effect. 

Tegafur; drug polymorphism; relative humidity; solvent vapor effect; polymorph transition kinetics; X-ray diffraction